Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543892 | SCV000639018 | benign | Transposition of the great arteries, dextro-looped | 2024-09-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763795 | SCV000894709 | uncertain significance | Transposition of the great arteries, dextro-looped; Cardiac anomalies - developmental delay - facial dysmorphism syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002526114 | SCV003716159 | likely benign | Inborn genetic diseases | 2021-08-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004691876 | SCV005192009 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004537968 | SCV004721052 | likely benign | MED13L-related disorder | 2021-03-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |